Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery
Sponsor: Benha University
Summary
Cesarean section (CS) is one of the most frequently performed surgical procedures globally, with an increasing demand for safe and effective anesthesia techniques. Regional anesthesia, particularly intrathecal anesthesia, has become the method of choice for elective cesarean deliveries.The most commonly used local anesthetic for intrathecal anesthesia is bupivacaine.Recent studies have focused on adjunctive agents to enhance the efficacy of local anesthetics.
Official title: Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery ;Arandomized Non - Inferiority Study
Key Details
Gender
FEMALE
Age Range
20 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2026-03-15
Completion Date
2026-10-15
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
Bupivacaine
patient will receive intra-thecal hyperbaric bupivacaine 11 mg(2.2 ml) of 0.5% bupivacaine, with 0.5 ml of normal saline in total volume 2.5 ml.
Bupivacaine and Dexmedetomidine
patient will receive 9 mg (1.8 ml) of 0. 5% bupivacaine, with 5 μg of DEX in 0.5ml of normal saline in total volume 2.5 ml.
Locations (1)
Banha Faculity of Medicine
Banhā, Elqalyoubea,, Egypt